Literature DB >> 21960712

Severe viral infections and primary immunodeficiencies.

Lesia K Dropulic1, Jeffrey I Cohen.   

Abstract

Patients with severe viral infections are often not thoroughly evaluated for immunodeficiencies. In this review, we summarize primary immunodeficiencies that predispose individuals to severe viral infections. Some immunodeficiencies enhance susceptibility to disease with a specific virus or family of viruses, whereas others predispose to diseases with multiple viruses in addition to disease with other microbes. Although the role of cytotoxic T cells in controlling viral infections is well known, a number of immunodeficiencies that predispose to severe viral diseases have recently been ascribed to defects in the Toll-like receptor-interferon signaling pathway. These immunodeficiencies are rare, but it is important to identify them both for prognostic information and for genetic counseling. Undoubtedly, additional mutations in proteins in the innate and adaptive arms of the immune system will be identified in the future, which will reveal the importance of these proteins in controlling infections caused by viruses and other pathogens.

Entities:  

Mesh:

Year:  2011        PMID: 21960712      PMCID: PMC3189169          DOI: 10.1093/cid/cir610

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  49 in total

1.  Practice parameter for the diagnosis and management of primary immunodeficiency.

Authors:  Francisco A Bonilla; I Leonard Bernstein; David A Khan; Zuhair K Ballas; Javier Chinen; Michael M Frank; Lisa J Kobrynski; Arnold I Levinson; Bruce Mazer; Robert P Nelson; Jordan S Orange; John M Routes; William T Shearer; Ricardo U Sorensen
Journal:  Ann Allergy Asthma Immunol       Date:  2005-05       Impact factor: 6.347

2.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

Review 3.  Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.

Authors:  Gérard Orth
Journal:  Semin Immunol       Date:  2006-10-02       Impact factor: 11.130

Review 4.  The range of defects associated with nuclear factor kappaB essential modulator.

Authors:  Gulbu Uzel
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-12

5.  XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.

Authors:  Stéphanie Rigaud; Marie-Claude Fondanèche; Nathalie Lambert; Benoit Pasquier; Véronique Mateo; Pauline Soulas; Lionel Galicier; Françoise Le Deist; Frédéric Rieux-Laucat; Patrick Revy; Alain Fischer; Geneviève de Saint Basile; Sylvain Latour
Journal:  Nature       Date:  2006-11-02       Impact factor: 49.962

Review 6.  Human natural killer cell deficiencies.

Authors:  Jordan S Orange
Journal:  Curr Opin Allergy Clin Immunol       Date:  2006-12

7.  Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

Authors:  Yoshiyuki Minegishi; Masako Saito; Tomohiro Morio; Ken Watanabe; Kazunaga Agematsu; Shigeru Tsuchiya; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Hideo Kaneko; Naomi Kondo; Ikuya Tsuge; Akihiro Yachie; Yukio Sakiyama; Tsutomu Iwata; Fumio Bessho; Tsutomu Ohishi; Kosuke Joh; Kohsuke Imai; Kazuhiro Kogawa; Miwa Shinohara; Mikiya Fujieda; Hiroshi Wakiguchi; Srdjan Pasic; Mario Abinun; Hans D Ochs; Eleonore D Renner; Annette Jansson; Bernd H Belohradsky; Ayse Metin; Norio Shimizu; Shuki Mizutani; Toshio Miyawaki; Shigeaki Nonoyama; Hajime Karasuyama
Journal:  Immunity       Date:  2006-11       Impact factor: 31.745

8.  Herpes simplex virus encephalitis in human UNC-93B deficiency.

Authors:  Armanda Casrouge; Shen-Ying Zhang; Céline Eidenschenk; Emmanuelle Jouanguy; Anne Puel; Kun Yang; Alexandre Alcais; Capucine Picard; Nora Mahfoufi; Nathalie Nicolas; Lazaro Lorenzo; Sabine Plancoulaine; Brigitte Sénéchal; Frédéric Geissmann; Koichi Tabeta; Kasper Hoebe; Xin Du; Richard L Miller; Bénédicte Héron; Cyril Mignot; Thierry Billette de Villemeur; Pierre Lebon; Olivier Dulac; Flore Rozenberg; Bruce Beutler; Marc Tardieu; Laurent Abel; Jean-Laurent Casanova
Journal:  Science       Date:  2006-09-14       Impact factor: 47.728

9.  TLR3 deficiency in patients with herpes simplex encephalitis.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Sophie Ugolini; Asma Smahi; Gaëlle Elain; Pedro Romero; David Segal; Vanessa Sancho-Shimizu; Lazaro Lorenzo; Anne Puel; Capucine Picard; Ariane Chapgier; Sabine Plancoulaine; Matthias Titeux; Céline Cognet; Horst von Bernuth; Cheng-Lung Ku; Armanda Casrouge; Xin-Xin Zhang; Luis Barreiro; Joshua Leonard; Claire Hamilton; Pierre Lebon; Bénédicte Héron; Louis Vallée; Lluis Quintana-Murci; Alain Hovnanian; Flore Rozenberg; Eric Vivier; Frédéric Geissmann; Marc Tardieu; Laurent Abel; Jean-Laurent Casanova
Journal:  Science       Date:  2007-09-14       Impact factor: 47.728

Review 10.  Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Vanessa Sancho-Shimizu; Horst von Bernuth; Kun Yang; Laurent Abel; Capucine Picard; Anne Puel; Jean-Laurent Casanova
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

View more
  30 in total

1.  Adoptive T cell therapy for the treatment of viral infections.

Authors:  Reuben J Arasaratnam; Ann M Leen
Journal:  Ann Transl Med       Date:  2015-10

2.  Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.

Authors:  Jeffrey I Cohen; Lesia Dropulic; Amy P Hsu; Christa S Zerbe; Tammy Krogmann; Kennichi Dowdell; Ronald L Hornung; Jana Lovell; Nancy Hardy; Dennis Hickstein; Edward W Cowen; Katherine R Calvo; Stefania Pittaluga; Steven M Holland
Journal:  Clin Infect Dis       Date:  2016-05-11       Impact factor: 9.079

3.  Periodic Illness Associated With Epstein-Barr Virus: A New Diagnosis After a 22-Year Follow-up.

Authors:  Lesia K Dropulic; Mir A Ali; Amanda K Ombrello; Jeffrey I Cohen
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

Review 4.  Challenges and Clinical Implications of the Diagnosis of Cytomegalovirus Lung Infection in Children.

Authors:  Sonia M Restrepo-Gualteros; Maria J Gutierrez; Milena Villamil-Osorio; Maria A Arroyo; Gustavo Nino
Journal:  Curr Infect Dis Rep       Date:  2019-05-30       Impact factor: 3.725

5.  The Immunogenetics of Photodermatoses.

Authors:  Chaw-Ning Lee; Tzu-Ying Chen; Tak-Wah Wong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 6.  The challenge of developing a herpes simplex virus 2 vaccine.

Authors:  Lesia K Dropulic; Jeffrey I Cohen
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

7.  Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.

Authors:  Mandy Glass; Roger D Everett
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

8.  STAT2 deficiency and susceptibility to viral illness in humans.

Authors:  Sophie Hambleton; Stephen Goodbourn; Dan F Young; Paul Dickinson; Siti M B Mohamad; Manoj Valappil; Naomi McGovern; Andrew J Cant; Scott J Hackett; Peter Ghazal; Neil V Morgan; Richard E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-07       Impact factor: 11.205

9.  Targeting Conserved Sequences Circumvents the Evolution of Resistance in a Viral Gene Drive against Human Cytomegalovirus.

Authors:  Marius Walter; Rosalba Perrone; Eric Verdin
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

Review 10.  The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.

Authors:  Soren Gantt; William J Muller
Journal:  Clin Dev Immunol       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.